Bicara Therapeutics CEO Quietly Sold Shares. Her 339,000-Share Stake Speaks Louder.

What: Bicara Therapeutics CEO quietly sold **339,000** shares, reducing her stake in the company.
Why: The sale may indicate a lack of confidence in the company's future prospects.
Signal: The sale of a significant portion of her stake could be a bearish signal for investors.
Target: Investors may target the company's stock price for a potential decline following the CEO's sale.
Risk: The sale increases the risk of a stock price drop, potentially impacting investor returns.